Last reviewed · How we verify
5ALA
At a glance
| Generic name | 5ALA |
|---|---|
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Application site pain
- Application site erythema
- Application site pruritus
- Application site exfoliation
- Application site scab
- Application site oedema
- Application site paraesthesia
- Application site induration
- Application site erosion
- Hypoalbuminaemia
- Application site discharge
- Application site vesicles
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 5ALA CI brief — competitive landscape report
- 5ALA updates RSS · CI watch RSS
- Tel-Aviv Sourasky Medical Center portfolio CI